Related references
Note: Only part of the references are listed.HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption
Johannes F. Scheid et al.
NATURE (2016)
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort
Elise Landais et al.
PLOS PATHOGENS (2016)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Wan-Lin Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117
Marina Caskey et al.
NATURE (2015)
Antibody responses to envelope glycoproteins in HIV-1 infection
Dennis R. Burton et al.
NATURE IMMUNOLOGY (2015)
Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies
Jinal N. Bhiman et al.
NATURE MEDICINE (2015)
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
Hyejin Yoon et al.
NUCLEIC ACIDS RESEARCH (2015)
Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising
Shishi Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Insights into the trimeric HIV-1 envelope glycoprotein structure
Andrew B. Ward et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Virological features associated with the development of broadly neutralizing antibodies to HIV-1
Penny L. Moore et al.
TRENDS IN MICROBIOLOGY (2015)
The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection
Valerie Cortez et al.
PLOS PATHOGENS (2015)
Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
Peter Hraber et al.
AIDS (2014)
Impact of Clade, Geography, and Age of the Epidemic on HIV-1 Neutralization by Antibodies
Peter Hraber et al.
JOURNAL OF VIROLOGY (2014)
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
Nicole A. Doria-Rose et al.
NATURE (2014)
Early development of broadly neutralizing antibodies in HIV-1-infected infants
Leslie Goo et al.
NATURE MEDICINE (2014)
Development of broadly neutralizing antibodies from autologous neutralizing antibody responses in HIV infection
Cynthia A. Derdeyn et al.
CURRENT OPINION IN HIV AND AIDS (2014)
Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
Garnett Kelsoe et al.
VACCINES (2014)
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
Florian Klein et al.
CELL (2013)
Human Circulating PD-1+CXCR3-CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses
Michela Locci et al.
IMMUNITY (2013)
HIV-1 neutralizing antibodies: understanding nature's pathways
John R. Mascola et al.
IMMUNOLOGICAL REVIEWS (2013)
Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys
Emmi Andersson et al.
INFECTION GENETICS AND EVOLUTION (2013)
Residue-Level Prediction of HIV-1 Antibody Epitopes Based on Neutralization of Diverse Viral Strains
Gwo-Yu Chuang et al.
JOURNAL OF VIROLOGY (2013)
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Hua-Xin Liao et al.
NATURE (2013)
Delineating Antibody Recognition in Polyclonal Sera from Patterns of HIV-1 Isolate Neutralization
Ivelin S. Georgiev et al.
SCIENCE (2013)
Antibodies in HIV-1 Vaccine Development and Therapy
Florian Klein et al.
SCIENCE (2013)
Viral Escape from HIV-1 Neutralizing Antibodies Drives Increased Plasma Neutralization Breadth through Sequential Recognition of Multiple Epitopes and Immunotypes
Constantinos Kurt Wibmer et al.
PLOS PATHOGENS (2013)
A Blueprint for HIV Vaccine Discovery
Dennis R. Burton et al.
CELL HOST & MICROBE (2012)
Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies
Peter D. Kwong et al.
IMMUNITY (2012)
Genetic Diversity as a Marker for Timing Infection in HIV-Infected Patients: Evaluation of a 6-Month Window and Comparison With BED
Manon Ragonnet-Cronin et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Longitudinal Analysis of Early HIV-1-Specific Neutralizing Activity in an Elite Neutralizer and in Five Patients Who Developed Cross-Reactive Neutralizing Activity
Zelda Euler et al.
JOURNAL OF VIROLOGY (2012)
HIV-1 Env antibodies: are we in a bind or going blind?
John P. Moore
NATURE MEDICINE (2012)
Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Diversity and Tropism in 145 Patients With Primary HIV-1 Infection
Philip Rieder et al.
CLINICAL INFECTIOUS DISEASES (2011)
Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection
Roger D. Kouyos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
Peter Rusert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
The Role of Migration and Domestic Transmission in the Spread of HIV-1 Non-B Subtypes in Switzerland
Viktor von Wyl et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
Characteristics of the Earliest Cross-Neutralizing Antibody Response to HIV-1
Iliyana Mikell et al.
PLOS PATHOGENS (2011)
HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men
Philip Rieder et al.
AIDS (2010)
Cohort Profile: The Swiss HIV Cohort Study
Franziska Schoeni-Affolter et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2010)
Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland
Roger D. Kouyos et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables
Nicole A. Doria-Rose et al.
JOURNAL OF VIROLOGY (2010)
A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals
Laura M. Walker et al.
PLOS PATHOGENS (2010)
Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection
D. Noah Sather et al.
JOURNAL OF VIROLOGY (2009)
Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm
Melissa D. Simek et al.
JOURNAL OF VIROLOGY (2009)
Breadth of Neutralizing Antibody Response to Human Immunodeficiency Virus Type 1 Is Affected by Factors Early in Infection but Does Not Influence Disease Progression
Anne Piantadosi et al.
JOURNAL OF VIROLOGY (2009)
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James M. Binley et al.
JOURNAL OF VIROLOGY (2008)
A joint back calculation model for the imputation of the date of HIV infection in a prevalent cohort
Patrick Taffe et al.
STATISTICS IN MEDICINE (2008)
Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
Amandeep K. Dhillon et al.
JOURNAL OF VIROLOGY (2007)
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
A Trkola et al.
NATURE MEDICINE (2005)
Deliberate removal of T cell help improves virus-neutralizing antibody production
M Recher et al.
NATURE IMMUNOLOGY (2004)
Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines
DC Montefiori et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Antibody neutralization and escape by HIV-1
XP Wei et al.
NATURE (2003)
Share Paper
